Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 8/2013

01-10-2013 | Original Paper

Disease Progression and Characteristics of HIV-infected Women With and Without a History of Criminal Justice Involvement

Authors: Eren Youmans, James Burch, Robert Moran, Lillian Smith, Wayne A. Duffus

Published in: AIDS and Behavior | Issue 8/2013

Login to get access

Abstract

Early HIV diagnosis followed by prompt linkage to and consistent retention in HIV-related care is important to decrease morbidity and mortality. Progression to AIDS is of particular interest in HIV-positive women with a history of criminal justice-involvement due to their lack of access to care in the community and poor retention in HIV primary care. In this retrospective cohort study, we characterize the risk of developing AIDS among HIV-infected women with and without a history of criminal justice-involvement. Mean time to AIDS diagnosis was longer [123 ± 3.26 months] for women with no criminal justice-involvement when compared to women who were arrested or who went to prison. Women who were arrested (HR: 1.92, 95% CI: 1.43, 2.58) and women who went to prison (HR: 2.27, 95% CI: 1.52, 3.39) had an increased risk of developing AIDS when compared to women without criminal justice-involvement.
Literature
1.
Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. New Engl J Med. 1998;338(13):853–60.PubMedCrossRef
2.
Jacobson MA, French M. Alternated natural history of AIDS-related opportunistic infections in the era of potent combination antiretroviral therapy. AIDS. 1998;12(Suppl A):S157–63.PubMed
3.
Murphy EL, Collier AC, Kalish LA, Assman SF, Para MF, Flanigan TP, et al. Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced disease. Ann Intern Med. 2001;135:17–26.PubMedCrossRef
4.
Langford SE, Ananworanich J, Cooper DA. Predictors of disease progression in HIV infection: a review. AIDS Res Ther. 2007;4(11):1–14.
5.
Nicastri E, Angeletti C, Palmisano L, Sarmati L, Chiesi A, Geraci A, et al. Gender differences in clinical progression of HIV-1 infected individuals during long-term highly active antiretroviral therapy. AIDS. 2005;19:577–83.PubMedCrossRef
6.
Melnick SL, Sherer R, Louis TA, Hillman D, Rodriguez EM, Lackman C, et al. Survival and disease progression according to gender of patients with HIV infection. JAMA. 1994;272(22):1915–21.PubMedCrossRef
7.
Del Amo J, Petruckevitch A, Phillips A, Johnson AM, Stephenson J, Desmond N, et al. Disease progression and survival in HIV-1-infected Africans in London. AIDS. 1998;12(10):1203–9.PubMedCrossRef
8.
Poundstone KE, Chaisson RE, Moore RD. Differences in HIV disease progression by injection drug use and by sex in the era of highly active antiretroviral therapy. AIDS. 2001;15:1115–23.PubMedCrossRef
9.
Clark RA, Blakley SA, Rice J, Brandon W. Predictors of HIV disease progression in women. J Acquir Immune Defic Syndr. 1995;9(1):43–50.
10.
Laine C, Markson LE, McKee LJ, Hauck WW, Fanning TR, Turner BJ. The relationship of clinic experience with advanced HIV and survival of women with AIDS. Am J Public Health. 1997;12(4):417–24.
11.
Griffin MM, Ryan JG, Briscoe VS, Shadle KM. Effects of Incarceration on HIV-Infected Individuals. J Natl Med Assoc. 2010;88(10):639–44.
12.
Khan MR, Wohl DA, Weir SS, Adimora A, Moseley C, Norcott K, et al. Incarceration and risky sexual partnerships in a Southern US City. J Urban Health. 2007;28(1):100–13.
13.
Khan MR, Doherty IA, Schoenbach VJ, Taylor EM, Epperson MW, Adimora AA. Incarceration and high-risk sex partnerships among men in the United States. J Urban Health. 2011;86(4):584–601.CrossRef
14.
Spaulding A, Stephenson W, Macalino G, Ruby W, Clarke JG, Flanigan TP. Human immunodeficiency virus in correctional facilities: a review. CID. 2002;35(3):305–12.CrossRef
15.
Meyer JP, Chen NE, Springer SA. HIV treatment in the criminal justice system: critical knowledge and intervention gaps. AIDS Res Treat. 2011;2011:680617. doi:10.​1155/​2011/​680617.
16.
Mahajan AP, Sayles JN, Patel VA, Remien RR, Ortiz D, Szekeres G, et al. Stigma in the HIV/AIDS epidemic: a review of the literature and recommendations for the way forward. AIDS. 2008;22(Suppl 2):S67–79.PubMedCrossRef
17.
Baillargeon J, Giordano TP, Harzke AJ, Spaulding AC, Wu ZH, Grady JJ, et al. Predictors of reincarceration and disease progression among released HIV-infected inmates. AIDS Patient Care STDs. 2010;24(6):389–94.PubMedCrossRef
18.
Palepu A, Tyndall MW, Chan K, Wood E, Montaner JSG, Hogg RS. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes. Antivir Ther. 2004;9:713–9.PubMed
19.
20.
Panel of Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services; 2008.
21.
Ghali WA, Quan H, Brant R, Melle G, Norris CM, Faris PD, et al. Comparison of 2 methods for calculating adjusted survival curves from proportional hazards models. JAMA. 2001;286(12):1494–7.PubMedCrossRef
22.
The White House Office of National AIDS Policy. National HIV/AIDS Strategy for the United States; 2011.
23.
The Constitution of thre United States of America, Amendment 8; 2010.
24.
Stephenson BL, Wohl DA, Golin CD, Tien HC, Stewart P, Kaplan AH. Effect of release from prison and re-incarceration on the viral load of HIV-infected individuals. Public Health Rep. 2005;120:84–8.PubMed
25.
Springer SA, Pesanti E, Hodges J, Macura T, Doros G, Altice FL. Effectiveness of antiretroviral therapy among HIV-infected prisoners: reincarcertation and the lack of sustained benefit after release to the community. CID. 2004;38:1754–60.CrossRef
26.
Rich JD, Holmes L, Salas C, Macalino G, Davis D, Ryczek J, et al. Successful linkage of medical care and community services for HIV-positive offenders being released from prison. J Urban Health. 2001;78(2):279–89.PubMedCrossRef
27.
Centers for Disease Control and Prevention. Centers for Disease Control Prevention. Program collaboration and service integration: enhancing the prevention and control of HIV/AIDS, viral hepatitis, sexually transmitted diseases, and tuberculosis in the United States. US Department of Health and Human Services; 2009.
28.
Cheever LW. Engaging HIV-infected patients in care: their lives depend on it. CID. 2007;44:1500–2.CrossRef
29.
Cunningham WE, Anderson RM, Katz MH, Stein MD, Turner BJ, Crystal S, et al. The impact of competing subsistence needs and barriers on access to medical care for persons with human immunodeficiency virus receiving care in the United States. Med Care. 1999;37(12):1270–80.PubMedCrossRef
30.
Raveis VH, Seigel K, Gorey E. Factors associated with HIV-infected women’s delay in seeking medical care. AIDS Care. 1998;10:549–62.PubMedCrossRef
31.
Giordano TP, Gifford AL, White CA, Suarez-Almazor ME, Rabeneck L, Hartman C, et al. Retention in care: a challenge to survival with HIV infection. CID. 2007;44:1493–9.CrossRef
32.
Cunningham CO, Sohler NL, Wong MD, Relf M, Cunningham WE, Drainoni ML, et al. Utilization of health care services in hard-to-reach marginalized HIV-infected individuals. AIDS Patient Care STDs. 2007;21(3):177–86.PubMedCrossRef
Metadata
Title
Disease Progression and Characteristics of HIV-infected Women With and Without a History of Criminal Justice Involvement
Authors
Eren Youmans
James Burch
Robert Moran
Lillian Smith
Wayne A. Duffus
Publication date
01-10-2013
Publisher
Springer US
Published in
AIDS and Behavior / Issue 8/2013
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-011-0057-1

Other articles of this Issue 8/2013

AIDS and Behavior 8/2013 Go to the issue

Original Paper

Cost and Threshold Analysis of an HIV/STI/Hepatitis Prevention Intervention for Young Men Leaving Prison: Project START

Original Paper

Does Effective Depression Treatment Alone Reduce Secondary HIV Transmission Risk? Equivocal Findings from a Randomized Controlled Trial

Original Paper

Multilevel Stigma as a Barrier to HIV Testing in Central Asia: A Context Quantified

Original Paper

HIV Risk Behaviors of Male and Female Jail Inmates Prior to Incarceration and One Year Post-Release

Original Paper

Relationships Between Marijuana Dependence and Condom Use Intentions and Behavior Among Justice-Involved Adolescents

Original Paper

Context Matters: The Moderating Role of Bar Context in the Association Between Substance Use During Sex and Condom Use Among Male Clients of Female Sex Workers in Tijuana, Mexico
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits